ADIPOQ and metabolic dysfunction-associated steatohepatitis: A significant increase in adiponectin expression in the liver after genistein treatment was observed only in the OVX rats (NASH+Gen vs. NASH; 1.45 ± 0.83 vs. 0.71 ± 0.27, respectively; p < 0.05) but not in the non-OVX ones (NASH+Gen vs. NASH; 11.19 ± 0.40 vs. 0.68 ± 0.35, respectively; p = 0.120) (Figure 9).